|
Report Date : |
26.06.2012 |
IDENTIFICATION DETAILS
|
Name : |
NOVARTIS
CONSUMER HEALTH S.A. |
|
|
|
|
Registered Office : |
Route de
l'Etraz Case postale 1279 1260 Nyon 1 |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Date of Incorporation : |
12.03.1908 |
|
|
|
|
Com. Reg. No.: |
550.0.071.293-1
/ 390935 |
|
|
|
|
Legal Form : |
Company
limited by shares |
|
|
|
|
Line of Business : |
Manufacture
of basic pharmaceutical products |
|
|
|
|
No. of Employees : |
8'000-9'999 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Good |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Switzerland |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
NOVARTIS CONSUMER HEALTH S.A.
Operating address:
Route de l'Etraz
Case postale 1279
1260 Nyon 1
Switzerland/CH
Telephone: 022
3633111
Fax: 022
3621744
Web site: http://www.consumer-health.ch
E-mail: info@novartis-consumer-health.ch
VAT-No.: CHE102429188
Established: 1908
Line of Business: Pharmaceutics, Food
Industry Division: Manufacturing
Industry-code (NACE): 2120 Manufacture of
pharmaceutical preparations
2110 Manufacture of basic pharmaceutical
products
1086 Manufacture of homogenised food
preparations and dietetic food
Import/Export: Export
Banks: unknown
Coverage: Group
Employees: 8'000-9'999
Sales: USD
4-6 Bil
The business activities
includes the manufacture and distribution of products for the health and
welfare of consumers and patients.
Information on
property ownership was not available.
Company No: 550.0.071.293-1
/ 390935
Legal form: Company
limited by shares
Registration: 12.03.1908
Legal status: active
Responsible Register: Registre du commerce du canton de Vaud (since 08.05.1991)
History: Date
of Statutes: 30.04.1999
Date
of Statutes: 08.05.1991
Entry Deleted Name
active NOVARTIS
CONSUMER HEALTH S.A.
active NOVARTIS
CONSUMER HEALTH AG (Name translated)
active NOVARTIS
CONSUMER HEALTH Inc. (Name translated)
01.01.1996 Zyma SA
removed Zyma Pharma SA
removed Zyma Limited (Name translated)
removed Zyma AG (Name translated)
Entry Deleted Legal domicile
active Prangins,
Switzerland
removed Nyon, Switzerland
Entry Deleted Address
active Route
de l'Etraz, 1197 Prangins/VD, Switzerland/CH
Entry Deleted Capital
active Share
Capital CHF 30'000'000, paidup CHF 30'000'000
Entry Deleted Capital Structure
active 300'000
Registered shares of CHF 100.--
Entry Deleted Activity (original Language)
active Réaliser
en tous pays, pour le compte de tiers, en participation avec des tiers, toutes
opérations ou affaires, gérer ou constituer toutes entreprises commerciales,
financières ou industrielles, même immobilières, ayant un rapport avec la
fabrication ou la vente de produits chimiques, pharmaceutiques, sanitaires,
alimentaires ou destinés d'une manière ou d'une autre au domaine de la santé.
Entry Deleted Remarks (original Language)
active Publishing
authority: Feuille officielle suisse du commerce.
15.12.2006 Merger:
Reprise des actifs et passifs de Max Ritter Pharma SA, à Prangins (CH-550-0110280-5),
selon contrat de fusion du 27 novembre 2006 et bilan au 30 septembre 2006,
présentant des actifs de CHF 2'479'288.59, des passifs envers les tiers de CHF
16'123.00, soit un actif net de CHF 2'463'165.59. La société reprenante
détenant l'ensemble des actions de la société transférante, la fusion ne donne
pas lieu à une augmentation du capital, ni à une attribution d'actions.
29.04.2003 Merger:
La fusion a lieu sans augmentation du capital-actions dans la mesure où les
actions de la société absorbante et de la société absorbée sont détenues par
les mêmes actionnaires.
29.04.2003 Merger:
Selon contrat de fusion du 28 mars 2003 et bilan au 31 décembre 2002, la
société reprend à titre universel et sans liquidation, au sens de l'art. 748
CO, l'actif (CHF 126'472'885.90) et le passif (CHF 116'257'392.47), soit un
actif net de CHF 10'215'493.43, de la société Novartis Consumer Health
International S.A., à Prangins.
Title Name
President Dr.
Daniel L. Vasella, Origin: Poschiavo, Switzerland, Residential address: Risch,
Switzerland, joint signature of two
Company Secretary Anne Tailleur, Origin: Charmey, Switzerland,
Residential address: 1173 Féchy/VD, Switzerland, joint signature of two
Executive Director Felix Ehrat , Origin: Lohn , Switzerland,
Residential address: Zumikon, Switzerland, joint signature of two, Registered
since: 25.01.2012
Executive Director Naomi Kelman , Origin: United States of
America, Residential address: New Jersey, United States of America, joint signature
of two, Registered since: 23.08.2011
Executive Director Jonathan Symonds , Origin: United Kingdom,
Residential address: 4000 Bâle/BS, Switzerland, joint signature of two,
Registered since: 04.05.2010
Title Name
Member with signing authority Bryant Aaron, Origin: United States of
America, Residential address: Nyon, Switzerland, joint signature of two
Member with signing authority Isabelle Augsburger, Origin: Langnau im
Emmental, Switzerland, Residential address: Genève, Switzerland, joint
signature of two
Member with signing authority Gabriele Baretta , Origin: Bâle,
Switzerland, Residential address: 4125 Riehen/BS, Switzerland, joint signature
of two, Registered since: 21.01.2010
Member with signing authority Christine Eising, Origin: Germany,
Residential address: 1196 Gland /VD, Switzerland, joint signature of two,
Registered since: 22.04.2009
Member with signing authority Lutz Hegemann, Origin: Germany,
Residential address: 1180 Rolle/VD, Switzerland, joint signature of two,
Registered since: 22.04.2009
Member with signing authority Martin Heinrich, Origin: Bâle,
Switzerland, Residential address: Riehen, Switzerland, Joint signature of five
Member with signing authority Tobias Hestler, Origin: Meilen, Switzerland,
Residential address: Zurich , Switzerland, joint signature of two, Registered
since: 08.02.2011
Member with signing authority Pierre Humbert-Droz, Origin: Le Locle,
Switzerland, Residential address: 1239 Collex-Bossy/GE, Switzerland, joint signature
of two, Registered since: 22.04.2009
Member with signing authority Barbara Kessler, Origin: Davos,
Switzerland, Residential address: Pfäffikon, Switzerland, joint signature of
two
Member with signing authority Stefan Looks, Origin: Germany, Residential
address: Saint-Prex , Switzerland, joint signature of two
Member with signing authority Pascal Mühlemann, Origin: Alchenstorf,
Switzerland, Residential address: 1260 Nyon/VD, Switzerland, joint signature of
two
Member with signing authority Simon Nash, Origin: United Kingdom,
Residential address: Bâle, Switzerland, joint signature of two
Member with signing authority Erick Reinartz, Origin: Germany,
Residential address: Lutry, Switzerland, joint signature of two
Member with signing authority Mark Riordan, Origin: United States of
America, Residential address: Coppet, Switzerland, joint signature of two
Member with signing authority Alexandre Rochat , Origin: Lieu,
Switzerland, Residential address: 1121 Bremblens/VD, Switzerland, joint
signature of two, Registered since: 02.09.2010
Member with signing authority Peter Rupprecht, Origin: Bâle,
Switzerland, Residential address: Aesch /BL, Switzerland, joint signature of
two
Member with signing authority Dominique Sallin, Origin:
Villaz-Saint-Pierre, Switzerland, Residential address: Gland, Switzerland,
joint signature of two
Member with signing authority Jacek Stachnio , Origin: Poland,
Residential address: 1197 Prangins/VD, Switzerland, joint signature of two,
Registered since: 09.12.2009
Member with signing authority Bernard Tonascia, Origin: Genève,
Switzerland, Residential address: Grens, Switzerland, joint signature of two
Member with signing authority Esteban Uriarte , Origin: United States
of America, Residential address: 1176 Saint-Livres/VD, Switzerland, joint
signature of two, Registered since: 09.12.2009
Member with signing authority Sven Van Gyseghem, Origin: Belgium,
Residential address: 1295 Tannay/VD, Switzerland, joint signature of two,
Registered since: 22.04.2009
Member with signing authority Christoph Wild , Origin: Saint-Gall,
Switzerland, Residential address: 4125 Riehen/BS, Switzerland, joint signature
of two, Registered since: 14.07.2010
Member with signing authority Philippe Zell, Origin: Naz, Switzerland,
Residential address: 1009 Pully/VD, Switzerland, joint signature of two,
Registered since: 22.04.2009
Title Name
Auditor PricewaterhouseCoopers
SA, Residential address: Genève, Switzerland
Consolidation: consolidated
(Segment)
Industry: Trade/Industry
Fiscal year end: 31.12.2011 31.12.2010 31.12.2009 31.12.2008 31.12.2007
Number of months: 12 12 12 12 12
Currency: mil.
USD mil.
USD mil. USD mil. USD mil. USD
Operating revenue 4'646.0 6'204.0 5'812.0 5'812.0 5'426.0
Operating result 727.0 1'153.0 1'016.0 1'048.0 812.0
Total shareholders equity 1'724.0 3'208.0 3'168.0 3'179.0 3'154.0
Total assets 2'684.0 4'480.0 4'508.0 4'491.0 4'529.0
Depreciation 109.0 103.0 99.0 103.0 117.0
Investments in tangible fixed assets 74.0 150.0 164.0 160.0 209.0
Research and Development 296.0 359.0 346.0 313.0 301.0
Full time units at year end 8'290 13'136 12'539 13'014 13'956
Consolidation: consolidated
Industry: Trade/Industry
Fiscal year end: 31.12.2011 31.12.2010 31.12.2009 31.12.2008 31.12.2007
Number of months: 12 12 12 12 12
Currency: mil.
USD mil.
USD mil. USD mil. USD mil. USD
Statement norm: IAS IAS IAS IAS IAS
Balance Sheet
Intangible fixed assets 61'912.0 64'923.0 22'370.0 20'819.0 21'249.0
Land and buildings 9'746.0 7'164.0 6'207.0 5'473.0 5'240.0
Other tangible fixed assets 5'881.0 8'676.0 7'868.0 7'627.0 7'393.0
Tangible fixed assets 15'627.0 15'840.0 14'075.0 13'100.0 12'633.0
Financial fixed assets 9'598.0 10'630.0 25'041.0 23'207.0 6'945.0
other fixed assets 6'275.0 5'240.0 328.0 292.0 7'195.0
Fixed assets 93'412.0 96'633.0 61'814.0 57'418.0 48'022.0
Stocks 5'930.0 6'093.0 5'830.0 5'792.0 5'455.0
Trade accounts receivable 10'323.0 9'873.0 8'310.0 7'026.0 6'648.0
Liquid assets 3'709.0 5'319.0 2'894.0 2'038.0 5'360.0
Securities 1'366.0 2'815.0 14'555.0 4'079.0 7'841.0
other trade accounts 2'050.0 1'843.0 1'700.0 1'946.0 2'126.0
Accruals 706.0 742.0 402.0
Other current assets 7'831.0 10'719.0 19'551.0 8'063.0 15'327.0
Current assets 24'084.0 26'685.0 33'691.0 20'881.0 27'430.0
Total assets 117'496.0 123'318.0 95'505.0 78'299.0 75'452.0
Capital 1'016.0 957.0 957.0 959.0 990.0
Other shareholders funds 64'828.0 62'239.0 56'430.0 49'329.0 48'233.0
Total shareholders equity 65'844.0 63'196.0 57'387.0 50'288.0 49'223.0
Minority interests 96.0 6'573.0 75.0 149.0 173.0
long term debt (financial debts) 13'855.0 14'360.0 8'675.0 2'178.0 677.0
Provisions 7'792.0 6'842.0 5'491.0 5'036.0 4'272.0
Other non current liabilities 6'761.0 7'689.0 4'407.0 4'144.0 4'466.0
Non current liabilities 28'408.0 28'891.0 18'573.0 11'358.0 9'415.0
short term debt (financial debts) 6'374.0 8'627.0 5'313.0 5'186.0 5'117.0
Trade accounts payable 4'989.0 4'788.0 4'012.0 3'395.0 3'018.0
Provisions 7'055.0 6'414.0 5'633.0 4'517.0
Accruals 895.0 931.0 1'181.0 914.0
other accounts payable 3'835.0 3'898.0 3'331.0 2'492.0 8'506.0
other current liabilities 11'785.0 11'243.0 10'145.0 7'923.0 8'506.0
Current liabilities 23'148.0 24'658.0 19'470.0 16'504.0 16'641.0
Shareh. equity, min. interests + liabilities 117'496.0 123'318.0 95'505.0 78'299.0 75'452.0
Profit and loss account
Net sales 58'566.0 50'624.0 44'267.0 41'459.0 38'072.0
Other operating revenue 2'163.0 2'171.0 836.0 1'125.0 875.0
Operating revenue 60'729.0 52'795.0 45'103.0 42'584.0 38'947.0
Cost of goods sold 18'983.0 14'488.0 12'179.0 11'439.0 11'032.0
Gross profit 41'746.0 38'307.0 32'924.0 31'145.0 27'915.0
Other operating expenses 30'748.0 26'781.0 22'942.0 22'181.0 15'706.0
Operating result 10'998.0 11'526.0 9'982.0 8'964.0 12'209.0
Interest revenues 62.0 103.0 198.0 384.0 531.0
other financial revenues 721.0 873.0 293.0 441.0 412.0
Financial income 783.0 976.0 491.0 825.0 943.0
Interest expenses 751.0 692.0 551.0 290.0 237.0
other financial expenses 257.0 108.0 0.0 0.0 0.0
Financial expenses 1'008.0 800.0 551.0 290.0 237.0
Financial result -225.0 176.0 -60.0 535.0 706.0
Result before extraordinary items 10'773.0 11'702.0 9'922.0 9'499.0 12'915.0
Result before taxes 10'773.0 11'702.0 9'922.0 9'499.0 12'915.0
Taxes 1'528.0 1'733.0 1'468.0 1'336.0 947.0
Result before minority interests 9'245.0 9'969.0 8'454.0 8'163.0 11'968.0
minority interests 132.0 175.0 54.0 38.0 22.0
Result for the financial year 9'113.0 9'794.0 8'400.0 8'125.0 11'946.0
Cash flow
Depreciation 1'728.0 1'363.0 1'025.0 1'205.0 1'130.0
Cash flow 10'973.0 11'332.0 9'479.0 9'368.0 13'098.0
Cash flow from operating activities 14'309.0 14'067.0 12'191.0 9'769.0 9'210.0
Investments in tangible fixed assets 2'167.0 1'678.0 1'887.0 2'106.0 2'549.0
Cash flow from investing activities -792.0 -15'756.0 -14'219.0 -10'367.0 -6'244.0
Cash flow from financing activities -15'024.0 4'116.0 2'809.0 -2'573.0 -9'318.0
Others -103.0 -2.0 75.0 -151.0 7'897.0
Change in liquidity -1'610.0 2'425.0 856.0 -3'322.0 1'545.0
Liquidity at beginning of the year 5'319.0 2'894.0 2'038.0 5'360.0 3'815.0
Liquidity at end ot the year 3'709.0 5'319.0 2'894.0 2'038.0 5'360.0
Notes
Material costs 18'983.0 14'488.0 12'179.0 11'439.0 11'032.0
Cost of employees 14'913.0 12'240.0 10'920.0 10'634.0 9'893.0
Research and Development 9'583.0 9'070.0 7'469.0 7'217.0 6'430.0
Added value 28'165.0 25'997.0 22'418.0 21'628.0 13'152.0
Working Capital 11'264.0 11'178.0 10'128.0 9'423.0 9'085.0
Sales per Employee 0.5 0.4 0.4 0.4 0.4
Market capitalisation 137'511.0 133'731.0 124'000.0 113'200.0 123'889.0
Gross cost land and buildings 14'424.0 11'501.0 10'089.0 9'218.0 8'617.0
Gross cost other tangible fixed assets 15'511.0 17'456.0 15'811.0 14'755.0 14'183.0
Gross cost total 29'935.0 28'957.0 25'900.0 23'973.0 22'800.0
Insurance value total 34'483.0 32'288.0 27'147.0 28'595.0 24'194.0
Full time units at year end 123'686 119'418 99'834 96'717 98'200
Employees inland 13'548 12'500 12'000 11'300 12'022
Employees abroad 110'138 106'918 87'834 85'417 86'178
Name: Novartis
AG
City/Country: Basel,
Switzerland/CH
No. of Owner/-s: 1
Owner: The
company is domestic owned.
Class: 100%
Name: Novartis
AG
City/Country: Basel,
Switzerland/CH
Interest: 100.00%
voting right, 100.00% capital interest
It is believed that
the company has no investments.
Control date Year No. Amount CHF Status
07.03.2012 2012 0
07.03.2012 2011 0
07.03.2012 2010 0
07.03.2012 2009 2 191'725.-- Legal actions
07.03.2012 2008 0
07.03.2012 2007 0
An updated legal
action check is only available against proof of interest. e.g. a copy of an
enquiry letter, and order or invoice relating to the subject company.
Debt collection
case:
SEP 2009: CHF 750.00, booked up.
NOV 2008: CHF
13'479.00, booked up.
Financial Situation: The financial situation is good.
Payment experiences: Payments are made with arranged conditions.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.56.53 |
|
|
1 |
Rs.88.09 |
|
Euro |
1 |
Rs.70.83 |
INFORMATION DETAILS
|
Report Prepared
by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.